Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1164508 BOSTON, MA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,560,201
+$1,105,568 QoQ
Shares Held
106,644
+240.1% QoQ
Ownership
0.797%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 134 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. ANIK ranks #23 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,137,442 $225,456,582
2 VTRS
Viatris Inc
 8,371,218 $132,934,941
3 HLN
Haleon plc
 14,181,817 $132,316,352
4 INDV
Indivior Pharmaceuticals, Inc.
 1,642,086 $67,374,788
5 KNSA
Kiniksa Pharmaceuticals International, plc
 957,514 $61,233,020
6 TAK
Takeda Pharmaceutical Co Ltd
 3,732,924 $59,838,771
7 ANIP
Ani Pharmaceuticals Inc
 562,016 $46,523,684
8 ELAN
Elanco Animal Health Inc
 1,872,157 $46,073,783

All Filings in ANIK

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,560,201 106,644
2026-03-31 $454,633 31,354
2025-12-31 $509,272 52,994
2025-09-30 $498,143 52,994
2025-06-30 $560,676 52,994
2025-03-31 $880,682 58,595
2024-12-31 $978,629 59,455
2024-09-30 $2,687,187 108,793
2024-06-30 $2,755,726 108,793
2024-03-31 $3,043,402 119,819
2023-12-31 $5,042,076 222,510
2023-09-30 $2,591,693 139,114
2021-12-31 $1,071,531 29,906
2021-09-30 $1,263,861 29,696
2021-06-30 $2,167,140 50,061
2020-06-30 $1,779,158 47,155
2020-03-31 $2,254,690 77,990